ATLASJohnson & Johnson (JNJ) earnings date: expected January 8–14
Johnson & Johnson (JNJ) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 8–14. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on JNJ
| Last price | $273.20 (-0.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.5% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 6 reports |
| Dividend | $5.28 a year (1.93% yield) · next ex-date Nov 24, 2026 |
These figures come from the same calibrated model and valuation as the Johnson & Johnson stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 8–14 (estimate). One email the day before, with ATLAS’s read on Johnson & Johnson. You can switch it off at any time.
Alert me before JNJ reportsFree to start. Creating an account takes under a minute.
JNJ earnings at a glance
| Next report | Not announced · expected around January 8–14 (ATLAS estimate) |
|---|---|
| Last report | Oct 13, 2026 · Beat |
| Beat rate (last 6 reports) | 3 of 6 (50%) |
| Average EPS surprise | +20.1% |
| Average move around a report | ±1.5% (last 6) |
| Sector | Healthcare · Drug Manufacturers - General |
The expected window is an ATLAS estimate: it takes the typical gap between Johnson & Johnson’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Johnson & Johnson earnings history: last 6 reports
Johnson & Johnson last reported on Oct 13, 2026: EPS of $2.59 against an estimate of $2.53 (+2.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 13, 2026 | $2.53 | $2.59 | +2.4% | Beat | -3.8% |
| Jul 15, 2026 | $2.85 | $2.90 | +1.8% | In line | -1.5% |
| Apr 14, 2026 | $2.68 | $2.70 | +0.7% | In line | +0.3% |
| Jan 21, 2026 | $2.46 | $2.46 | 0.0% | In line | +0.1% |
| Dec 9, 2025 | $0.18 | $0.38 | +111.1% | Beat | +2.4% |
| Oct 17, 2025 | $0.66 | $0.69 | +4.5% | Beat | +0.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for JNJ
See the fair value, the probability range and the earnings history of Johnson & Johnson on its ATLAS page.
Johnson & Johnson (JNJ) stock analysisPlans from €3.99 a month.
Johnson & Johnson earnings: frequently asked questions
When is Johnson & Johnson (JNJ) next earnings date?
Johnson & Johnson has not announced its next report. Its last 4 reports came Oct 13, 2026, Jul 15, 2026, Apr 14, 2026, Jan 21, 2026, so ATLAS estimates the next one around January 8–14. This is an estimate based on that pattern, not a confirmed date.
How often does JNJ beat earnings estimates?
Of its last 6 reports with a recorded result, Johnson & Johnson beat the EPS estimate 3 times; the average surprise was +20.1%. Past results do not predict the next one.
How much does JNJ move around earnings?
Over its last 6 reports the stock moved an average of 1.5% (absolute, from the close before the report day to the close after it), and finished higher 4 of 6 times.
Did Johnson & Johnson beat earnings estimates last quarter?
Johnson & Johnson last reported on Oct 13, 2026: EPS of $2.59 against an estimate of $2.53 (+2.4% surprise), a beat.
How much does JNJ usually move in a day?
On a normal trading day the ATLAS model puts JNJ’s one-day range at about ±1.5%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer